The testing menu comprises over 300 tests, including, but not limited to: basic and comprehensive metabolic panels; hepatic function panel; toxicology and therapeutic drug monitoring; tumor markers (i.e., CA123, CA153, and PSA); endocrine function tests such as thyroid stimulating hormone (“TSH”), T3, and T4; serum and urine pregnancy testing (qualitative and quantitative); and hormones such as parathyroid hormone (“PTH”), adrenocorticotropic hormone (“ACTH”), luteinizing hormone (“LH”), and testosterone. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it.